Relsys International announced six new clients for 2006, the company’s 20th anniversary. The company said Pfizer, Otsuka and Solvay had switched from competing drug safety products. Other wins include Pronova AS, Sciclone Pharmaceuticals, and Avexa. Existing customers as Lilly, Novartis, Allergan, Shire, and Novo-Nordisk, Relsys said, were expanding their use of software and services.

Here’s a quote from the news release:

“Twenty years ago, we founded the company with a vision of working with the leading pharmaceutical companies to develop drug safety solutions that met their needs, and would revolutionize the way the industry managed this critical function,” said Dave Bajaj, President and CEO. “It’s humbling and gratifying that as we celebrate our 20th anniversary, we are acknowledged as the industry leader, and have seen our products grow to meet the regulatory reporting and pharmacovigilance needs of pharmaceutical companies around the world.”